Member Info for Sangijuelas1

BioNTech, they got a lot more money to throw at it now

And yet he has been calling it correctly for over 6 months. And those people hanging on for the cancer treatments might want to take a look at other therapies and mrna vaccines for cancer that will render chemo redundant.

Mate, I think the only ones left here are the ones that are going to end up drinking the Kool aid

For warning me off guys. Was thinking of having a punt here but reading your comments I think I will give it a miss.

I was told they couldn't by A J Bell, not looking to mislead anyone

So an issue for the Spac investors to concern themselves with. Not investors in the target company.

Has put up 5m for the backstop for the LOAC deal so maybe reducing to account for that?
It's the 2nd recent reduction by him.

In you go to the filter box.

Did you know that you can save the planet by generating massive amounts of green energy by applying the filter button?

I think it's a bot

Green boxes

Yeah, good point, was just trying a conservative estimate of future revenue. Hence suggesting product on market 2026 when could get there earlier.

Market for IBS in the US is estimated to be 2.4bn per year in 2024. This is thought to be an underestimate as many patients discontinue existing treatments due to the side effects and no treatment available for IBS-M. So say 1.5bn share of market goes to Blautix with drug on market by 2026. Patent protected until 2036 so 10 years would be 15bn.
I would say that would be worth a significant upfront payment to take development of it off 4D's hands.
More detailed Blautix data is due before year end.

In 2014 Celgene paid a small Irish pharma called Nogra Pharma 710m USD upfront to take a drug for Chron's disease through Phase 3. The drug failed the trial but if successful they would have had a further 2bn to cough up.

It's a Backstop finance arrangement. I think it is unlikely to be called on. They are not the only ones providing it as it matches the whole of the Loac cash

Ok that's what I wanted to know as I haven't seen a clear explanation of how the warrants are going to work

What share price you lot got in at?

The registration says they are getting 17.7% of the company.
Wake up!

I have read the filing. Any ideas why the Longevity share of the combined company is 13.1% in the original merger RNS and showing as 17.7% on the SEC registration form?

Same as it ever was. Used to be lucky if you got 5 posts a week on the board a year or so back.

The FDA can also allow treatment with unapproved drugs in certain circumstances, which means MRX 0518 could be allowed to be used in patients who could otherwise die.
https://www.fda.gov/news-events/public-health-focus/expanded-access#:~:text=Sometimes%20called%20%E2%80%9Ccompassionate%20use%E2%80%9D%2C,clinical%20trials%20when%20no%20comparable